Akari Therapeutics Plc buy krebskrebs
Start price
02.04.24
/
50%
€1.35
Target price
02.04.25
€2.20
Performance (%)
123.70%
Price
29.08.24
€3.02
Summary
This prediction is currently active. The BUY prediction by krebskrebs for Akari Therapeutics Plc has seen massive gains of 123.70%. This prediction currently runs until 02.04.25. The prediction end date can be changed by krebskrebs at any time. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Akari Therapeutics Plc | -7.362% | -7.362% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by krebskrebs for this prediction
In the thread Akari Therapeutics Plc diskutieren
Buy mit Kursziel 2,2